Literature DB >> 31602591

Upregulation of secreted aspartyl proteinase genes of fluconazole-sensitive Candida albicans isolates.

Carolina do Rosário Esteves Guimarães1,2, Humberto Fonseca de Freitas1, Tânia Fraga Barros3,4.   

Abstract

Candida albicans infection development depends on several factors associated with this etiological agent, including secreted aspartyl protease (Sap) production. Sap expression commonly occurs under selective pressure caused by the presence of antifungals. Fluconazole is the main antifungal drug used for treatment or prophylaxis. This study investigated the influence of inhibitory and sub-inhibitory fluconazole concentrations on Sap activity and their gene transcription for three clinical C. albicans isolates. Two isolates presented significant increases in Sap activity and transcription of SAP 1-8 genes in the presence of 1 MIC80 of fluconazole compared to the absence of the antifungal agent. The results suggest that the increase in Sap activity occurs due to an upregulation of the SAP gene transcription influenced by fluconazole. This suggests the importance of all SAP genes in the progression of bloodstream infections compared to primary tissue infection. However, this phenomenon does not occur everywhere, and it is multifactorial. This may be related to the selective pressure effect on transcription modulators. Although preliminary, these results open a new perspective for the study of virulence factors.

Entities:  

Keywords:  Candida albicans; Fluconazole; Secreted aspartyl protease; Virulence factors

Mesh:

Substances:

Year:  2019        PMID: 31602591     DOI: 10.1007/s11033-019-05049-2

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  34 in total

Review 1.  Candida albicans: a review of its history, taxonomy, epidemiology, virulence attributes, and methods of strain differentiation.

Authors:  M J McCullough; B C Ross; P C Reade
Journal:  Int J Oral Maxillofac Surg       Date:  1996-04       Impact factor: 2.789

Review 2.  Global trends in the distribution of Candida species causing candidemia.

Authors:  J Guinea
Journal:  Clin Microbiol Infect       Date:  2014-03-06       Impact factor: 8.067

Review 3.  Epidemiology of Candida albicans infections and role of non-Candida-albicans yeasts.

Authors:  Markus Ruhnke
Journal:  Curr Drug Targets       Date:  2006-04       Impact factor: 3.465

Review 4.  Early diagnosis of fungal infection in immunocompromised patients.

Authors:  Rosemary A Barnes
Journal:  J Antimicrob Chemother       Date:  2008-01       Impact factor: 5.790

Review 5.  Vulvovaginal candidosis.

Authors:  Jack D Sobel
Journal:  Lancet       Date:  2007-06-09       Impact factor: 79.321

Review 6.  Molecular epidemiology, phylogeny and evolution of Candida albicans.

Authors:  Brenda A McManus; David C Coleman
Journal:  Infect Genet Evol       Date:  2013-11-19       Impact factor: 3.342

Review 7.  Oral candidiasis.

Authors:  A Akpan; R Morgan
Journal:  Postgrad Med J       Date:  2002-08       Impact factor: 2.401

8.  Candida albicans Niche Specialization: Features That Distinguish Biofilm Cells from Commensal Cells.

Authors:  Sanna E Herwald; Carol A Kumamoto
Journal:  Curr Fungal Infect Rep       Date:  2014-06-01

Review 9.  Emerging and emerged pathogenic Candida species: beyond the Candida albicans paradigm.

Authors:  Nicolas Papon; Vincent Courdavault; Marc Clastre; Richard J Bennett
Journal:  PLoS Pathog       Date:  2013-09-26       Impact factor: 6.823

10.  Epidemiology and Microbiologic Characterization of Nosocomial Candidemia from a Brazilian National Surveillance Program.

Authors:  André Mario Doi; Antonio Carlos Campos Pignatari; Michael B Edmond; Alexandre Rodrigues Marra; Luis Fernando Aranha Camargo; Ricardo Andreotti Siqueira; Vivian Pereira da Mota; Arnaldo Lopes Colombo
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

View more
  2 in total

1.  Metabolic profiling of Candida clinical isolates of different species and infection sources.

Authors:  Josidel Conceição Oliver; Luca Laghi; Carola Parolin; Claudio Foschi; Antonella Marangoni; Andrea Liberatore; Amanda Latercia Tranches Dias; Monica Cricca; Beatrice Vitali
Journal:  Sci Rep       Date:  2020-10-07       Impact factor: 4.379

2.  The effects of secreted aspartyl proteinase inhibitor ritonavir on azoles-resistant strains of Candida albicans as well as regulatory role of SAP2 and ERG11.

Authors:  Wenli Feng; Jing Yang; Yan Ma; Zhiqin Xi; Xiaoqin Zhao; Xiaoxia Zhao; Min Zhao
Journal:  Immun Inflamm Dis       Date:  2021-05-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.